When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management (Companion Faculty Lecture)
QUICKTIME•Episode home
Manage episode 507940731 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Featuring a slide presentation and related discussion from Prof Peter Schmid, including the following topics:
- Evolution of the therapeutic landscape for metastatic triple-negative breast cancer; age of immunotherapy (0:00)
- Case: A woman in her early 40s with no actionable mutations (7:29)
- Evolution of antibody-drug conjugates (ADCs) in the management of metastatic breast cancer (11:13)
- TROP2-directed ADCs (15:22)
- Case: A woman in her early 50s with PD-L1-negative, HR-negative, HER2-low de novo metastatic breast cancer (20:21)
- Novel strategies utilizing approved and investigational ADCs (23:28)
- Case: A woman in her early 60s with loss of HER2 expression on disease progression (31:39)
- ADCs in combination with immunotherapy (32:51)
842 episodes
QUICKTIME•Episode home
Manage episode 507940731 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Featuring a slide presentation and related discussion from Prof Peter Schmid, including the following topics:
- Evolution of the therapeutic landscape for metastatic triple-negative breast cancer; age of immunotherapy (0:00)
- Case: A woman in her early 40s with no actionable mutations (7:29)
- Evolution of antibody-drug conjugates (ADCs) in the management of metastatic breast cancer (11:13)
- TROP2-directed ADCs (15:22)
- Case: A woman in her early 50s with PD-L1-negative, HR-negative, HER2-low de novo metastatic breast cancer (20:21)
- Novel strategies utilizing approved and investigational ADCs (23:28)
- Case: A woman in her early 60s with loss of HER2 expression on disease progression (31:39)
- ADCs in combination with immunotherapy (32:51)
842 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.